The NIH has created the NIH StrokeNet to conduct small and large clinical trials and research studies to advance acute stroke treatment, stroke prevention, and recovery and rehabilitation following a stroke. This network of 25 regional centers across the U.S., which involves more than 200 hospitals, is designed to serve as the infrastructure and pipeline for exciting new potential treatments for patients with stroke and those at risk for stroke. In addition, NIH StrokeNet will provide an educational platform for stroke physicians and clinical trial coordinators.
In September 2013, the National Institutes of Health funded the stroke trials network, NIH StrokeNet. The StrokeNet infrastructure consists of 25 regional coordinating centers across the US, a national coordinating center at the University of Cincinnati, and a national data management center (Medical University of South Carolina). The primary goal of this network is to maximize efficiencies to develop, promote and conduct high-quality, multi-site clinical trials focused on key interventions in stroke prevention, treatment and recovery.
3712 participants, 259 speakers, 14 best poster award winners, 5 young investigators award winners, 56 sessions, 11 teaching courses, 5 workshops, 1027 poster presentation, 14 poster walks
It’s been 4 months since ESOC 2016 in Barcelona, and preparations for ESOC 2017 in Prague are already well underway.
ESOC 2016 gathered top leaders, researchers, and professionals from the field of stroke management and care. Participants witnessed amazing clinical trial presentations, innovative e-poster sessions, and great hands-on workshops.
Abstract Submission Opens for the International Stroke Conference and the Stroke Nursing Symposium in TWO WEEKS - Wednesday May 25
Lead the way to discovery in the fight against stroke by submitting your best science to this premiere educational event dedicated to the science and treatment of cerebrovascular disease.
The Medical University of South Carolina is offering a two-day Clinical Trials workshop on May 2-3 & August 18-19 in Charleston, SC. The workshop is divided into four half-day sessions: Study Design, Sample Size and Randomization, Interim Analysis and Data and Safety Monitoring, and Study Planning. Registration for each individual session is available at $150, or $500 to attend all four. The attached flyer contains additional information, or for additional inquiries contact June Watson:
The NINDS Clinical Trials Methodology Course (CTMC) is accepting applications for the 2016 cohort. The application deadline is February 28, 2016.
The CTMC is an intensive, engaging program designed to help junior investigators develop scientifically rigorous, yet practical clinical trial protocols. The course features a combination of distance learning activities and a residential course, along with small group mentorship from experienced clinical trialists and biostatisticians. The residential course will be held on August 7-11, 2016 in Ann Arbor, Michigan.
We are pleased to announce that the NINDS Clinical Trials Methodology Course (CTMC) is now accepting applications for the 2016 cohort. The CTMC is an intensive, engaging program designed to help junior investigators develop scientifically rigorous, yet practical clinical trial protocols. The CTMC features a combination of distance learning activities and a residential course, along with small group mentorship from experienced clinical trialists and biostatisticians.
Prepare your research now while there is still plenty of time. NEW, this year, WSC 2016 will only have E-Posters. Goodbye, paper. Hello, Innovation. E-posters can increase the impact and scope of your work by making it accessible all year long to your colleagues and professional networks.
One World Voice for Stroke....
One of the highlights of the World Stroke Congress is the joint sessions with Stroke and Health Organisations around the world in our global fight to reduce the global and regional burden of stroke.
At WSC 2016, there will be joint sessions with:
Small businesses may apply for cooperative agreement grants: StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01) (PAR-14-220) OR through our Small Business program: StrokeNet Small Business Innovation in Clinical Trials (U44).
Industry may apply for expedited access to StrokeNet expertise and infrastructure through the StrokeNet Infrastructure Resource Access (X01) under a cost-sharing arrangement and Cooperative Research and Development Agreement (CRADA) with NINDS.
Grants For NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01)
previous daynext daytoday
NIH StrokeNet Education “Pathophysiological Links between Migraine and Stroke”; Presented by Cenk Ayata, MD, Harvard Medical School, Massachusetts General Hospital NIH StrokeNet Education “Pathophysiological Links between Migraine and Stroke”; Presented by Cenk Ayata, MD, Harvard Medical School, Massachusetts General HospitalNIH StrokeNet Education “Pathophysiological Links between Migraine and Stroke.
Treatments for acute stroke include IV t-PA, stroke centers, stroke units, endovascular thrombectomy devices for selected patients, nimodipine for subarachnoid hemorrhage, and aneurysm coiling and clipping for ruptured aneurysms. Intracerebral hemorrhage has proven to be the most challenging for effective treatments; however recent research has shown promise
Despite the advances made in acute stroke care, stroke remains the leading cause of adult disability in Americans. World-wide there is an estimated 50 million stroke survivors coping with significant physical, cognitive and emotional deficits. The field of stroke recovery and restorative neuroscience is still young and provides a rich environment for innovative trials.